Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2026/03/12 01:16 EDT
Regular Hours
Last
 238.82
+0.56 (+0.24%)
Day High 
238.99 
Prev. Close
238.26 
1-M High
275.1 
Volume 
973.96K 
Bid
234.93
Ask
242.24
Day Low
234.465 
Open
236.85 
1-M Low
233.29 
Market Cap 
16.77B 
Currency 美元 
P/E 68.46 
%Yield -- 
10-SMA 243.3 
20-SMA 245.49 
50-SMA 262.57 
52-W High 354.88 
52-W Low 233.29 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.48/7.69
Enterprise Value
17.70B
Balance Sheet
Book Value Per Share
21.53
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
2.71B
Operating Revenue Per Share
22.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.